Log in

Relevant bibliographies by topics / Co-Medication / Journal articles

To see the other types of publications on this topic, follow the link: Co-Medication.

Journal articles on the topic 'Co-Medication'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Co-Medication.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Pinho, Eurides Santos, Giulia Chalub Santoro, Johnatan Martins Sousa, Nathália dos Santos Silva, Paula Cândida da Silva Dias, and Ana Lúcia Queiroz Bezerra. "COGESTÃO DA TERAPÊUTICA MEDICAMENTOSA: Do cuidado seguro à gestão autônoma da medicação." Psicologia e Saúde em Debate 10, no. 2 (2024): 393–405. http://dx.doi.org/10.22289/2446-922x.v10a2a23.

Full text

Abstract:

The objective was to describe the involvement of users of community mental health services in the co-management of medication therapy from the perspective of professionals. Descriptive and exploratory qualitative research carried out using a questionnaire and semi-structured interviews with 40 professionals from four Psychosocial Care Centers, analyzed through thematic content analysis with the help of the Atlas T.I software. Two categories emerged: 1. Involvement of users in co-management of therapy medicinal; 2. Autonomous Medication Management as a safe care strategy. The Autonomous Medicat

APA, Harvard, Vancouver, ISO, and other styles

2

WAGNER, TODD H., MICHELE HEISLER, and JOHN D. PIETTE. "Prescription drug co-payments and cost-related medication underuse." Health Economics, Policy and Law 3, no. 1 (2008): 51–67. http://dx.doi.org/10.1017/s1744133107004380.

Full text

Abstract:

AbstractCo-payments have been linked to the slowing growth in pharmaceutical spending over the last five years. However, patients with health problems frequently have difficulty affording their pharmacotherapy and fail to take their medication as prescribed. We examine the relationship between co-payment amounts and four types of cost-related underuse: taking fewer doses, postponing taking a medication, failing to fill a prescription at all, and taking medication less frequently than prescribed. We conducted a nationwide survey of US adults age 50 and over who take medication for a chronic con

APA, Harvard, Vancouver, ISO, and other styles

3

Yang, Bo Ram, Jong-Mi Seong, Nam-Kyong Choi, et al. "Co-Medication of Statins with Contraindicated Drugs." PLOS ONE 10, no. 5 (2015): e0125180. http://dx.doi.org/10.1371/journal.pone.0125180.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rosen, Dennis. "Lowering Medication Co-Payments to Reduce Costs." Clinical Pediatrics 51, no. 2 (2011): 107–8. http://dx.doi.org/10.1177/0009922811403303.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Tobi, Hilde, Adrianne Faber, Paul B. van den Berg, J. Wanzer Drane, and Lolkje TW de Jong-van den Berg. "Studying co-medication patterns: the impact of definitions." Pharmacoepidemiology and Drug Safety 16, no. 4 (2007): 405–11. http://dx.doi.org/10.1002/pds.1304.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

McGee, P., P. Hollywood, S. McConkey, and A. Weidmann. "CP-038 Co-medication in an infectious diseases clinic: The rate of co-medication omissions and the significance of interactions between co-medications and antiretrovirals." European Journal of Hospital Pharmacy 23, Suppl 1 (2016): A16.3—A17. http://dx.doi.org/10.1136/ejhpharm-2016-000875.38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Roka, Tara, and Melina Ghimire. "Medication Adherence among Hypertensive Patients Attending a Tertiary Care Hospital in Nepal." Journal of Nepal Health Research Council 17, no. 4 (2020): 521–27. http://dx.doi.org/10.33314/jnhrc.v17i4.2337.

Full text

Abstract:

Background: Drug therapy and adherence to the medication is critical to prevent complications of hypertension and more importantly in countries like Nepal where more than one quarter adults suffer from it. Primary aim was to measure adherence to anti-hypertensive medication and factors associated with low adherence.Methods: Morisky Medication Adherence Scale was used for measuring medication adherence and a structured questionnaire for measuring background and illness related factors in a cross-sectional study among 216 hypertensive patients in a tertiary care hospital selected through sequent

APA, Harvard, Vancouver, ISO, and other styles

8

Hintz, Andreas, Tim Umland, Gero Niess, Mehtap Guendogdu, Anika Moerner, and Frank Tacke. "Pharmacotherapy Profiles in People with Opioid Use Disorders: Considerations for Relevant Drug–Drug Interactions with Antiviral Treatments for Hepatitis C." Pathogens 10, no. 6 (2021): 648. http://dx.doi.org/10.3390/pathogens10060648.

Full text

Abstract:

People who inject drugs (PWID) are often affected by physical and psychological diseases and prone to co-medication. In Germany, about 50% of PWID are on opioid substitution therapy (OST). Comprehensive data on pharmacotherapy in these patients may help to select antiviral therapy against hepatitis C virus (HCV) infections and avoid drug–drug interactions (DDIs). We compared co-medication profiles based on statutory health insurance prescriptions (IQVIA database) of PWID (n = 16,693), OST (n = 95,023) and treated HCV patients (n = 7886). Potential DDIs with the most widely used HCV direct-acti

APA, Harvard, Vancouver, ISO, and other styles

9

Holmqvist, Malin, Linda Johansson, Bertil Lindenfalk, Johan Thor, and Axel Ros. "Older Persons’ and Health Care Professionals’ Design Choices When Co-Designing a Medication Plan Aiming to Promote Patient Safety: Case Study." JMIR Aging 6 (October 5, 2023): e49154. http://dx.doi.org/10.2196/49154.

Full text

Abstract:

Background Harm from medications is a major patient safety challenge among older persons. Adverse drug events tend to arise when prescribing or evaluating medications; therefore, interventions targeting these may promote patient safety. Guidelines highlight the value of a joint plan for continued treatment. If such a plan includes medications, a medication plan promoting patient safety is advised. There is growing evidence for the benefits of including patients and health care professionals in initiatives for improving health care products and services through co-design. Objective This study a

APA, Harvard, Vancouver, ISO, and other styles

10

Thangam, Mathar Mohideen Nagoor. "Level of adherence and associated factors to medication use in patients with diabetes mellitus." Rev Rene 25 (November 20, 2024): e94393. http://dx.doi.org/10.15253/2175-6783.20242594393.

Full text

Abstract:

Objective: to identify the level of medication adherence practices and associated factors among patients with diabetes mellitus. Methods: this cross-sectional descriptive study was conducted among diabetes mellitus patients at selected health centers in Tabuk, Saudi Arabia. A total of 218 participants were selected based on inclusion and exclusion criteria. The Medication Adherence Practice Scale with a maximum score of 50 was used to collect the data. Results: the mean medication adherence practice score was 28.64 ± 8.47, 65.1% of the participants had moderate adherence, 27.5% had high medica

APA, Harvard, Vancouver, ISO, and other styles

11

SARANYA, G., RAJU SMILELIN, R. SIVA, and K. Vivekanandan. "Barriers and methods of assessing medication adherence in geriatric populations." World Journal of Biology Pharmacy and Health Sciences 16, no. 1 (2023): 080–88. https://doi.org/10.5281/zenodo.10790014.

Full text

Abstract:

Geriatrics patients will have different co-morbidities this can antagonistically influence drug consistence. The reason of this article is to recognize different variables liable for low prescription consistence and measures to further develop the drug consistence. Older individuals are generally impacted with ongoing sickness like Hypertension, Diabetes mellitus, Osteoarthritis and so on. All these sicknesses require long haul therapy, poor compliance in this age bunch represents medicine wastage with inflated cost of medical care and significant deteriorating of the illness with handicap or

APA, Harvard, Vancouver, ISO, and other styles

12

BOERS, MAARTEN. "Effects of Co-medication with Glucocorticoids in Biologics Trials." Journal of Rheumatology 45, no. 11 (2018): 1605.1–1605. http://dx.doi.org/10.3899/jrheum.180151.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Pisani, Francesco. "Influence of co-medication on the metabolism of valproate." Pharmaceutisch Weekblad Scientific Edition 14, no. 3 (1992): 108–13. http://dx.doi.org/10.1007/bf01962698.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Persaud, Nav, Marleane Davidson, and Diane Charter. "Community members co-designing a trial of medication access." Canadian Medical Association Journal 190, Suppl (2018): S44—S45. http://dx.doi.org/10.1503/cmaj.180415.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Wagner, Judith, Christine Suessmair, and Hans-Walter Pfister. "Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin." Journal of Neurology 256, no. 7 (2009): 1182–83. http://dx.doi.org/10.1007/s00415-009-5078-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Kjellgren, Karin I., Johan Ahlner, and Roger Säljö. "Taking antihypertensive medication — controlling or co-operating with patients?" International Journal of Cardiology 47, no. 3 (1995): 257–68. http://dx.doi.org/10.1016/0167-5273(94)02203-u.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Holmqvist, Malin, Axel Ros, Bertil Lindenfalk, Johan Thor, and Linda Johansson. "How Older Persons and Health Care Professionals Co-designed a Medication Plan Prototype Remotely to Promote Patient Safety: Case Study." JMIR Aging 6 (April 7, 2023): e41950. http://dx.doi.org/10.2196/41950.

Full text

Abstract:

Background Harm from medications is a major patient safety challenge. Most adverse drug events arise when a medication is prescribed or reevaluated. Therefore, interventions in this area may improve patient safety. A medication plan, that is, a plan for continued treatment with medications, may support patient safety. Participation of patients in the design of health care products or services may improve patient safety. Co-design, as in the Double Diamond framework from the Design Council, England, can emphasize patient involvement. As the COVID-19 pandemic brought restrictions to face-to-face

APA, Harvard, Vancouver, ISO, and other styles

18

Yerys, Benjamin E., Sha Tao, Lindsay Shea, and Gregory L. Wallace. "Attention-Deficit/Hyperactivity Disorder in Medicaid-Enrolled Autistic Adults." JAMA Network Open 8, no. 2 (2025): e2453402. https://doi.org/10.1001/jamanetworkopen.2024.53402.

Full text

Abstract:

ImportanceAutistic adults experience suboptimal health outcomes. Likewise, attention-deficit/hyperactivity disorder (ADHD) is linked to poor health outcomes in the general population, yet little is known about co-occurring ADHD and its links with poor health outcomes among autistic adults.ObjectiveTo determine the prevalence of ADHD and ADHD medication prescriptions and to examine associations between health outcomes and both ADHD co-occurrence and ADHD medication prescriptions among autistic adults.Design, Setting, and ParticipantsPopulation-based cohort study of US Medicaid-enrolled adults a

APA, Harvard, Vancouver, ISO, and other styles

19

Emdin, Abby, Alexa Boblitz, Laura Maclagan, et al. "DESCRIBING THE EVOLUTION OF MEDICATION USE OVER TIME IN PEOPLE LIVING WITH DEMENTIA USING NETWORK ANALYSIS." Innovation in Aging 6, Supplement_1 (2022): 778. http://dx.doi.org/10.1093/geroni/igac059.2815.

Full text

Abstract:

Abstract Prescribing for community-dwelling older adults living with dementia is complex. Multiple medications may be used to manage symptoms associated with dementia and/or co-existing chronic conditions, and can lead to problematic polypharmacy. Our objective was to use network analysis, a data science method, to provide a comprehensive description of co-prescribed medications in persons with dementia and describe whether these patterns change over time. We created a population-based cohort of community-dwelling older adults (aged 67+ years) in Ontario, Canada, newly diagnosed with dementia

APA, Harvard, Vancouver, ISO, and other styles

20

Ringe, Johann D., Stefan A. P. van der Geest, and Gerd M??ller. "Importance of Calcium Co-Medication in Bisphosphonate Therapy of Osteoporosis." Drugs & Aging 23, no. 7 (2006): 569–78. http://dx.doi.org/10.2165/00002512-200623070-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Menten, Johan. "Co-analgesics and adjuvant medication in opioid treated cancer pain." European Journal of Cancer Supplements 3, no. 3 (2005): 77–86. http://dx.doi.org/10.1016/s1359-6349(05)80264-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Bruessel, Thomas. "Co-medications, pre-medication and common diseases in the elderly." Best Practice & Research Clinical Anaesthesiology 17, no. 2 (2003): 179–90. http://dx.doi.org/10.1016/s1521-6896(03)00009-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Bosak, Magdalena, Agnieszka Słowik, Anna Iwańska, Milena Lipińska, and Wojciech Turaj. "Co-medication and potential drug interactions among patients with epilepsy." Seizure 66 (March 2019): 47–52. http://dx.doi.org/10.1016/j.seizure.2019.01.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Faber, Adrianne, Lolkje T. W. de Jong-van den Berg, Paul B. van den Berg, and Hilde Tobi. "Psychotropic Co-Medication among Stimulant-Treated Children in the Netherlands." Journal of Child and Adolescent Psychopharmacology 15, no. 1 (2005): 38–43. http://dx.doi.org/10.1089/cap.2005.15.38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Haring, T., and T. M. T. Mulders. "The combined contraceptive ring NuvaRing® and spermicide co-medication." Contraception 67, no. 4 (2003): 271–72. http://dx.doi.org/10.1016/s0010-7824(03)00002-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Verhoeven, C. H. J., M. W. van den Heuvel, T. M. T. Mulders, and Th O. M. Dieben. "The contraceptive vaginal ring, NuvaRing®, and antimycotic co-medication." Contraception 69, no. 2 (2004): 129–32. http://dx.doi.org/10.1016/j.contraception.2003.10.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

van Beusekom, H. M., R. Schoemaker, A. J. Roks, F. Zijlstra, and W. J. van der Giessen. "Coronary stent healing, endothelialisation and the role of co-medication." Netherlands Heart Journal 15, no. 11 (2007): 395–96. http://dx.doi.org/10.1007/bf03086022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Verheugt, Freek W. A. "Evidence-based co-medication in heart failure: necessary or bystander?" European Journal of Heart Failure 16, no. 1 (2013): 1–3. http://dx.doi.org/10.1002/ejhf.46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Heß, Tobias, Christian Oehlwein, and Thomas L. Milani. "Anticipatory Postural Adjustments and Compensatory Postural Responses to Multidirectional Perturbations—Effects of Medication and Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease." Brain Sciences 13, no. 3 (2023): 454. http://dx.doi.org/10.3390/brainsci13030454.

Full text

Abstract:

Background: Postural instability is one of the most restricting motor symptoms for patients with Parkinson’s disease (PD). While medication therapy only shows minor effects, it is still unclear whether medication in conjunction with deep brain stimulation (DBS) of the subthalamic nucleus (STN) improves postural stability. Hence, the aim of this study was to investigate whether PD patients treated with medication in conjunction with STN-DBS have superior postural control compared to patients treated with medication alone. Methods: Three study groups were tested: PD patients on medication (PD-ME

APA, Harvard, Vancouver, ISO, and other styles

30

Ahlawat, Saurabh, Vikrant Aggarwal, and Rakesh Kumar. "Medication compliance in schizophrenic out patients with psychoactive substance use co-morbidity: a cross-sectional study." International Journal of Research in Medical Sciences 10, no. 1 (2021): 167. http://dx.doi.org/10.18203/2320-6012.ijrms20215049.

Full text

Abstract:

Background: Medication adherence is an important issue in the treatment and management of persons with psychiatric disorders including schizophrenia. Apart from side effects and inefficient outcomes of psychiatric medications, substance abuse also complicates the adherence pattern to the prescribed medications. Present study was designed to estimate the magnitude of medication non-adherence and its correlates in patients with schizophrenia having co-morbid psychoactive substance use.Method: The 60 schizophrenic patients with active substance use were taken from OPD of institute of mental healt

APA, Harvard, Vancouver, ISO, and other styles

31

Behailu, Terefe Tesfaye* Teshale Ayele Mega Tsegaye Melaku Kebede. "PREVALENCE OF CO-MEDICATION AND POTENTIAL DRUG-DRUG INTERACTIONS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS ON HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY." INDO AMERICAN JOURNAL OF PHARMACEUTICAL RESEARCH 07, no. 09 (2017): 488–98. https://doi.org/10.5281/zenodo.1036376.

Full text

Abstract:

Background:-Drug interaction is an important therapeutic challenge among Human Immunodeficiency Virus infected patients. They are often observed in these patients because they frequently receive multiple medications. Though this may have clinical and economic impact, its prevalence is unknown in Ethiopia. So this study was aimed at addressing this issue by determining the prevalence of Co-medication and potential drug-drug interaction (PDDIs) in HIV infected patients. Method:- initially, checklist containing the relevant variables for the study was developed; ethical approval for patient medic

APA, Harvard, Vancouver, ISO, and other styles

32

Behailu, Terefe Tesfaye* Teshale Ayele Mega Tsegaye Melaku Kebede. "PREVALENCE OF CO-MEDICATION AND POTENTIAL DRUG-DRUG INTERACTIONS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS ON HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY." INDO AMERICAN JOURNAL OF PHARMACEUTICAL RESEARCH 07, no. 09 (2017): 488–98. https://doi.org/10.5281/zenodo.1036480.

Full text

Abstract:

Background:-Drug interaction is an important therapeutic challenge among Human Immunodeficiency Virus infected patients. They are often observed in these patients because they frequently receive multiple medications. Though this may have clinical and economic impact, its prevalence is unknown in Ethiopia. So this study was aimed at addressing this issue by determining the prevalence of Co-medication and potential drug-drug interaction (PDDIs) in HIV infected patients. Method:- initially, checklist containing the relevant variables for the study was developed; ethical approval for patient medic

APA, Harvard, Vancouver, ISO, and other styles

33

Bruin, Frans de, Karin Hek, Jan van Lieshout, et al. "Laxative co-medication and changes in defecation patterns during opioid use." Journal of Oncology Pharmacy Practice 25, no. 7 (2018): 1613–21. http://dx.doi.org/10.1177/1078155218801066.

Full text

Abstract:

Introduction Opioid-induced constipation is a clinically relevant side effect and a cause of potentially avoidable drug-related hospital admissions. Objectives To describe the presence of laxative co-medication, the reasons for not starting laxatives and to evaluate changes in stool patterns of opioid initiators. Methods In this observational study community pharmacists evaluated the availability of laxative co-medication in starting opioid users and registered reasons for non-use. Two opioid initiators per pharmacy were invited to complete questionnaires (‘Bristol stool form scale’ and ‘Rome

APA, Harvard, Vancouver, ISO, and other styles

34

Tussey, MD, Claudia C., Margaret D. Reyes, PharmD, Rosalinda B. Thomas, MEd LCAS, Charlotte T. Boyd, MA, CHES, John G. Spangler, MD, MPH, and Julienne K. Kirk, PharmD, CDE, BCPS. "Utility of the group medical visit model for medication-assisted therapy." Journal of Opioid Management 18, no. 1 (2022): 69–74. http://dx.doi.org/10.5055/jom.2022.0696.

Full text

Abstract:

Objective: To describe a group medical visit (GMV) model to facilitate medication assisted therapy.Design: Retrospective cohort analysis.Participants: Adult patients over 18 years of age desiring to receive medication assisted therapy (MAT).Methods: We describe the MAT GMV model including the clinical flow and group facilitation processes. The key elements for documentation and the medical portion of the visit are discussed. Using descriptive methods, we report the characteristics of our patient population entailing demographics, co-occurring mental health diagnosis, and medication use.Results

APA, Harvard, Vancouver, ISO, and other styles

35

Di Gangi, Stefania, Giuseppe Pichierri, Stefan Zechmann, Thomas Rosemann, and Andreas Plate. "Prescribing Patterns of Pain Medications in Unspecific Low Back Pain in Primary Care: A Retrospective Analysis." Journal of Clinical Medicine 10, no. 7 (2021): 1366. http://dx.doi.org/10.3390/jcm10071366.

Full text

Abstract:

Acute low back pain (LBP) is one of the most prevalent diseases worldwide. Since there is evidence of excessive prescriptions of analgesics, i.e., opioids, the aim of this study was to describe the use of pain medications in patients with LBP in the Swiss primary care setting. A retrospective, observational study was performed using medical prescriptions of 180 general practitioners (GP) during years 2009–2020. Patterns of pain medications (nonsteroidal anti-inflammatory drugs (NSAIDs), paracetamol, and opioids) as well as co-medications were analyzed in patients with a LBP diagnosis. Univaria

APA, Harvard, Vancouver, ISO, and other styles

36

Yeşilbağ, Zuhal, Emine İlay Şengül, Sevtap Şenoğlu, Özlem Altuntaş Aydın, and Hayat Kumbasar Karaosmanoğlu. "Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors." Current HIV Research 18, no. 6 (2020): 415–25. http://dx.doi.org/10.2174/1574885515666200812215140.

Full text

Abstract:

Background: Long life expectancy in people living with human immunodeficiency virus (PLWH) caused an increase in comorbidities and co-medications. We aimed to analyse co-medications and drug-drug interactions (DDIs) in antiretroviral therapy (ART)-naive PLWH in the era of integrase inhibitors. Methods: A retrospective observational study was conducted between January 2016-August 2019. Patients’ characteristics and chronic co-medications were recorded. The university of Liverpool HIV drug interaction database was used for DDIs. Results: Among 745 patients, the chronic co-medication rate was 30.

APA, Harvard, Vancouver, ISO, and other styles

37

Werner, Nicole, Aaron Ganci, Himalaya Patel, Teresa Thuemling, and Richard Holden. "CO-DESIGN OF A MOBILE APP FOR CARE PARTNERS WHO MANAGE MEDICATIONS FOR PEOPLE LIVING WITH DEMENTIA." Innovation in Aging 8, Supplement_1 (2024): 294. https://doi.org/10.1093/geroni/igae098.0959.

Full text

Abstract:

Abstract For unpaid care partners of community-dwelling people living with Alzheimer’s disease and related dementias (ADRD), medication management is effortful and time-consuming work that often continues over several years. Although this work may be eased by mobile application software (apps), current consumer apps underserve care partners’ needs. Through co-design workshops, our objective was to identify the user requirements for a mobile app supporting at-home medication management for people with ADRD. We conducted five 1-hour virtual co-design workshops with current and recent ADRD care p

APA, Harvard, Vancouver, ISO, and other styles

38

Kumar, Arvind, Surya Prakash, and Tulika Prasad. "Evaluation of Impact of Concomitant Drugs in Human Plasma on LC-MS/MS Based Quantification of Olmesartan and Hydrochlorothiazide." ECS Transactions 107, no. 1 (2022): 4449–57. http://dx.doi.org/10.1149/10701.4449ecst.

Full text

Abstract:

Liquid chromatography tandem mass spectrometer (LC-MS/MS) is an advanced analytical technique, which requires a validated method for a particular drug, prior to analysis of study samples. The analytical method must be selective with ability to distinguish between analyte of interest and endogenous or exogenous interferents (salts, proteins, lipids, metabolites, and concomitant medications). Concomitant medications are general treatment taken by subject population. Regulatory guidelines advocate evaluation of effects of co-medication on analytical methods, but detailed description of experiment

APA, Harvard, Vancouver, ISO, and other styles

39

CRIȘAN, CĂTĂLINA-ANGELA. "CHALLENGES REGARDING THE INTERACTION BETWEEN PSYCHOTROPICS AND COVID-19 CO-MEDICATION." FARMACIA 70, no. 3 (2022): 386–90. http://dx.doi.org/10.31925/farmacia.2022.3.2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Machado, C., B. Almeida, C. Fragoeiro, and L. Monteiro. "Myasthenia gravis: co-morbid psychiatric disorders and use of psychotropic medication." European Neuropsychopharmacology 27 (October 2017): S1036—S1037. http://dx.doi.org/10.1016/s0924-977x(17)31813-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

de Leon, Jose. "Psychopharmacology: Atypical Antipsychotic Dosing: The Effect of Co-medication With Anticonvulsants." Psychiatric Services 55, no. 2 (2004): 125–28. http://dx.doi.org/10.1176/appi.ps.55.2.125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

ALMESHARI, A., and R. KATKAR. "MEDICATION RELATED OSTEONECROSIS OF THE JAW CO-EXISTENT WITH OTHER LESIONS." Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 128, no. 4 (2019): e168. http://dx.doi.org/10.1016/j.oooo.2019.01.045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Waldeck, R., H. Kawabata, and Y. Yuan. "MD4: AUTOMATING ECONOMIC ANALYSIS OF CO-MEDICATION USE IN CLINICAL TRIALS." Value in Health 6, no. 3 (2003): 180. http://dx.doi.org/10.1016/s1098-3015(10)63807-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Wachman, Elisha M., A. Hutcheson Warden, Zoe Thomas, et al. "Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity." Drug and Alcohol Dependence 192 (November 2018): 45–50. http://dx.doi.org/10.1016/j.drugalcdep.2018.07.024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Fereshtehnejad, Seyed-Mohammad, Kristina Johnell, and Maria Eriksdotter. "Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer’s Disease." Drugs & Aging 31, no. 3 (2014): 215–24. http://dx.doi.org/10.1007/s40266-014-0154-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Carow, Florentine, Karin Rieger, Ingeborg Walter-Sack, et al. "Objective assessment of nonadherence and unknown co-medication in hospitalized patients." European Journal of Clinical Pharmacology 68, no. 8 (2012): 1191–99. http://dx.doi.org/10.1007/s00228-012-1229-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

DeGiorgio, Andrew C., Tamara E. Desso, Lance Lee, and Christopher M. DeGiorgio. "Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy." Epilepsy & Behavior Case Reports 1 (2013): 26–28. http://dx.doi.org/10.1016/j.ebcr.2012.10.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Voaklander, DC, KD Kelly, BH Rowe, et al. "#65 Medication use, co-morbidity and injury in older male farmers." Annals of Epidemiology 12, no. 7 (2002): 513–14. http://dx.doi.org/10.1016/s1047-2797(02)00353-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Bashir, Maryam. "Pattern of Self-medication and Associated Factors: A Study in Islamabad, Pakistan." Volume 3, Issue 1 III, no. I (2022): 17–26. http://dx.doi.org/10.55737/qjss.254768849.

Full text

Abstract:

The main objective was to identify the pattern of self-medication (use of medicinal products without prescription) and it’s associated socio-demographic factors (income, geographical area, gender, education level, e.t.c.) A cross-sectional study was carried out on a sample of 40 participants. Multi-stage sampling technique was used and sample was selected from 5 sectors and 5 sub-areas of the city. Univariate analysis was conducted for descriptive statistics. Two bivariate regression models were used. Self-medication and it’s relation to COVID-19 was also analysed. Most common symptoms for whi

APA, Harvard, Vancouver, ISO, and other styles

50

Domingues, Renan Barros, Esther Angélica Coelho Costa, Ariovaldo da Silva Jr, et al. "Correlation between migraine subtipes and depression." Arquivos de Neuro-Psiquiatria 66, no. 3a (2008): 485–87. http://dx.doi.org/10.1590/s0004-282x2008000400009.

Full text

Abstract:

This study has evaluated depression in patients with episodic migraine (n=98), chronic migraine without medication overuse (n=23), and chronic migraine with medication overuse (n=57). The Beck Depression Inventory (BDI) was used to evaluate depressive symptoms in these three groups. The mean BDI score obtained in all patients was higher than that observed in asymptomatic subjects (episodic migraine=16.09±11.79, chronic migraine with medication overuse=18.91±12.53, chronic migraine without medication overuse=19.83±14.79). This finding corroborates previous studies suggesting a co-morbid associa

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!